About 500 MG Aciclovir Intravenous Infusion IP
Advance your antiviral therapy with VENZURA MEDICOR's new release: 500 MG Aciclovir Intravenous Infusion IP. Engineered for potent efficacy, this stellar formulation capitalises on modern pharmaceutical standards to deliver a lofty approach against herpes simplex and varicella-zoster virus infections. Each glass vial contains lyophilised aciclovir (500 mg), ready to be reconstituted with sterile water for intravenous use only. Suitable for adults and children under hospital or clinical supervision, the preparation ensures powerful antiviral action. Store below 25C, shielded from light, and always check expiry for optimal outcomes.
Key Features and Specific Usage
500 MG Aciclovir Intravenous Infusion IP offers advanced antiviral efficacy in a convenient glass vial, accompanied by sterile water for injection. Designed for plant hospital and clinical application, this lyophilised powder effectively targets herpes simplex and varicella-zoster virus infections. Its potent formulation ensures reliable results and is recommended for both adults and children, as prescribed. This medication is strictly for slow intravenous infusion, requiring reconstitution prior to administration and is not suitable for intramuscular or subcutaneous use.
Payment Valuation & Global Transport
Valuation of 500 MG Aciclovir Intravenous Infusion IP depends on bulk order terms and is designed for competitive healthcare sectors. Goods transport is secured via reliable logistics for prompt, safe delivery. Main export markets include Asia and Gulf countries, reflecting wide trust in the product's quality. Delivery times are subject to destination-specific charges and shipping arrangements, ensuring efficient transit from India to your location, with careful handling to maintain the drug's potency and shelf life.
FAQ's of 500 MG Aciclovir Intravenous Infusion IP:
Q: How should 500 MG Aciclovir Intravenous Infusion IP be administered?
A: This medication must be reconstituted with provided sterile water and administered slowly through intravenous infusion, strictly under medical supervision. It is not suited for intramuscular or subcutaneous use.
Q: What are the primary benefits of choosing this intravenous aciclovir?
A: The principal benefit is its potent and targeted antiviral action against herpes simplex and varicella-zoster infections, ensuring rapid and effective management in hospital or clinical settings.
Q: When is the appropriate time for using this product?
A: It should be used upon diagnosis of herpes simplex or varicella-zoster infections, as prescribed by a physician, to promptly reduce viral severity and duration.
Q: Where is this medication supplied from and who manufactures it?
A: 500 MG Aciclovir Intravenous Infusion IP is manufactured and supplied from India by VENZURA MEDICOR, a trusted pharmaceutical provider.
Q: What is the process for reconstituting the product before administration?
A: Prior to infusion, the lyophilized powder must be reconstituted with the ampoule of sterile water for injection, as per the instructions provided, to ensure proper dissolution and dosage accuracy.
Q: Is this product suitable for both adults and children?
A: Yes, it is suitable for adults and children, but dosage and usage must strictly follow a qualified physician's directives.